Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
New Residential Investment Corp is a reit-mortgage business based in the US. New Residential Investment shares (NRZ) are listed on the NYSE and all prices are listed in US Dollars. New Residential Investment employs 6,126 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$11.14|
|52-week range||$6.87 - $11.13|
|50-day moving average||$10.31|
|200-day moving average||$10.47|
|Wall St. target price||$12.45|
|Dividend yield||$0.75 (6.84%)|
|Earnings per share (TTM)||$1.26|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||1.36%|
|1 month (2021-08-24)||6.50%|
|3 months (2021-06-24)||4.50%|
|6 months (2021-03-24)||3.15%|
|1 year (2020-09-24)||46.77%|
|2 years (2019-09-24)||-27.33%|
|3 years (2018-09-24)||18.23|
|5 years (2016-09-23)||14.26|
Valuing New Residential Investment stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of New Residential Investment's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
New Residential Investment's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, New Residential Investment shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
New Residential Investment's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 10.63. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into New Residential Investment's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$2.3 billion|
|Operating margin TTM||40.71%|
|Gross profit TTM||$-150,388,000|
|Return on assets TTM||2.14%|
|Return on equity TTM||11.29%|
|Market capitalisation||$5.1 billion|
TTM: trailing 12 months
There are currently 9.0 million New Residential Investment shares held short by investors – that's known as New Residential Investment's "short interest". This figure is 0.6% down from 9.1 million last month.
There are a few different ways that this level of interest in shorting New Residential Investment shares can be evaluated.
New Residential Investment's "short interest ratio" (SIR) is the quantity of New Residential Investment shares currently shorted divided by the average quantity of New Residential Investment shares traded daily (recently around 4.6 million). New Residential Investment's SIR currently stands at 1.98. In other words for every 100,000 New Residential Investment shares traded daily on the market, roughly 1980 shares are currently held short.
However New Residential Investment's short interest can also be evaluated against the total number of New Residential Investment shares, or, against the total number of tradable New Residential Investment shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case New Residential Investment's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 New Residential Investment shares in existence, roughly 20 shares are currently held short) or 0.0194% of the tradable shares (for every 100,000 tradable New Residential Investment shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against New Residential Investment.
Find out more about how you can short New Residential Investment stock.
Dividend payout ratio: 66.41% of net profits
Recently New Residential Investment has paid out, on average, around 66.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 9.1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), New Residential Investment shareholders could enjoy a 9.1% return on their shares, in the form of dividend payments. In New Residential Investment's case, that would currently equate to about $0.75 per share.
New Residential Investment's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
New Residential Investment's most recent dividend payout was on 28 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 September 2021 (the "ex-dividend date").
New Residential Investment's shares were split on a 1:2 basis on 19 October 2014. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your New Residential Investment shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for New Residential Investment shares which in turn could have impacted New Residential Investment's share price.
Over the last 12 months, New Residential Investment's shares have ranged in value from as little as $6.867 up to $11.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while New Residential Investment's is 1.9345. This would suggest that New Residential Investment's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
New Residential Investment Corp. , a real estate investment trust, focuses on investing in and managing residential mortgage related assets in the United States. It operates through five segments: Origination, Servicing, MSR Related Investments, Residential Securities and Loans, and Consumer Loans. The company invests in excess mortgage servicing rights (MSRs) on residential mortgage loans; and in servicer advances, including the basic fee component of the related MSRs. It also invests in real estate securities and residential mortgage loans, as well as in consumer loans, including unsecured and homeowner loans. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.